Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05916313
Title A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ESP | DEU | CHE


No variant requirements are available.